Please login to the form below
Oxford University
This page shows the latest Oxford University news and features for those working in and with pharma, biotech and healthcare.
Regeneron launches phase 3 COVID-19 antibody trial in the UK
Drug cocktail will be evaluated in patients hospitalised with COVID-19. Regeneron’s investigational antibody cocktail will be evaluated in a phase 3 trial coordinated by researchers from Oxford University as
Latest news
-
Trials resume for AZ/Oxford University COVID-19 vaccine
No further medical information was disclosed by AstraZeneca or the University of Oxford, the trial sponsor, for confidentiality reasons. ... In a statement, Oxford University said: “In large trials such as this one, it was expected that some
-
AZ pauses COVID-19 vaccine study after participant falls ill
A phase 1/2 study of AZ’s candidate, which it is co-developing with Oxford University, demonstrated positive results against SARS-CoV-2, the virus which causes COVID-19.
-
First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
The Oxford-based biotech company was co-founded by Mark Howarth and his team at Oxford University’s Department of Biochemistry and spun out with the help of Jenner Institute vaccinologists ... This year, the company raised £10m in funding from Oxford
-
American Medical Association calls for COVID-19 vaccine development transparency
Among the companies selected to receive funding as part of the initiative includes Johnson &Johnson, AstraZeneca/Oxford University, Pfizer/BioNTech, GlaxoSmithKline/Sanofi, Moderna and Novavax.
-
COVID-19 vaccine deals with the EU hindered by strict liability rules
The EU has currently only reached one supply agreement for a potential COVID-19 vaccine with AstraZeneca and Oxford University. ... Meanwhile, the UK has reached deals with J&J, Novavax, GlaxoSmithKline, Sanofi and AstraZeneca/Oxford University, although
More from news
Approximately 5 fully matching, plus 101 partially matching documents found.
Latest Intelligence
-
COVID-19: the race to find a vaccine
Multiple groups are advancing vaccines based on similar technology. University of Oxford researchers are enrolling volunteers in a trial of its adenovirus vaccine, while Johnson &Johnson and the US government have
-
Developing a COVID-19 vaccine
Researchers from Oxford University have also said they plan to start clinical trials of their COVID-19 vaccine this month. ... The CEPI has currently initiated eight COVID-19 vaccine developments with Curevac, Inovio Pharmaceuticals, Moderna, Novavax,
-
War games: why brand teams need a cunning plan that cannot fail
Who knows, it might well have been ‘as cunning as a fox who’d just been appointed Professor of Cunning at Oxford University’ – but his comrades never got to hear it
-
Biotech profile: Tom Evans, CEO, Vaccitech.
Vaccitech was launched in a spin-out from Oxford University in May 2016, with the aim of using its novel technology platform to develop a range of innovative new vaccines. ... You took the helm of Vaccitech when it was spun out Oxford University
-
The Big Book of Dashboards
He is also adjunct professor at the University of Cincinnati, where he teaches data visualisation, and was named the 2016 Outstanding Adjunct Professor of the Year. ... He has over ten years’ experience in data visualisation and business intelligence,
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Marinomed appoints CFO, Robin Brown is named chair of Medicines Discovery Catapult and more
Ian Walmsey, Pro-Vice-Chancellor Research &Innovation at the University of Oxford and Chair of the RFI’s Interim Board said: “I am delighted that Vivienne has agreed to be the ... I’ve seen how siloed some parts of science and corporate R&D can be
-
Paul Stockdale joins Oxford BioDynamics as CFO
He takes over from Katie Long, who has returned to her role within Tessera Investment Management, having previously established and led Oxford BioDynamics’ finance function. ... A spin-out from Oxford University, Oxford BioDynamics focuses on the
-
Martin Reeves joins Oxford BioDynamics
He takes up a senior vice president role. Oxford BioDynamics – a spin out company from the University of Oxford – has appointed Martin Reeves as its new senior vice president, commercial development. ... Christian Hoyer Millar, CEO at Oxford
-
Consilium appoints executive consultants
Standage (pictured right) joins the strategic healthcare communications firm from the University of Cambridge Judge Business School, having recently graduated with a degree in modern languages and management studies. ... Meanwhile Phillips (pictured left)
-
Healthcare at Home promotes Prof Sir Jonathan Asbridge
Formerly, Prof Asbridge served as chief nurse of the Oxford University and Cambridge University teaching hospitals, as well as chief nurse and interim chief executive of Barts and the London NHS
More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.
Latest from PMHub
-
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the world’s most influential scholarly and professional societies. ... Working in partnership with Oxford
-
For those who love science and storytelling — consider medical writing
It’s like watching a narrative unfurl before your eyes. During my time as a postdoc at the University of Oxford, I realised this was really what I enjoyed the most: ... I knew that I wanted to move away from the bench, and when I first learned about
-
A variety of backgrounds, a unified purpose
What did you do before you joined MedComms? I was a Post-doctoral Research Fellow working on Duchenne muscular dystrophy in the Department of Human Anatomy and Genetics at the University
-
International Women's Day - 8 March 2019
Malala is currently studying for a bachelor’s degree in Philosophy, Politics and Economics at Oxford University.
-
Bedrock strengthens Scientific Services team
Originally from New Zealand, Emily joins with almost 20 years' experience in medical strategy and communications having previously gained a PhD in Medicine from the University of Melbourne, before completing ... doctoral research at the University of
More from PMHub
Approximately 0 fully matching, plus 21 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Gilead agrees $21bn buyout of Immunomedics
- New medical communications agency BOLDSCIENCE launches
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- Moderna inks R&D agreements with Vertex and Chiesi
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Could formulary intelligence be your brand differentiator?
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Porterhouse Medical strengthens its senior management team
PMHub
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...
Latest intelligence
- Could formulary intelligence be your brand differentiator?
- Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
Quick links
Infographics
